Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 6.27M | P/E | - | EPS this Y | 42.20% | Ern Qtrly Grth | - |
| Income | -133.91M | Forward P/E | -0.09 | EPS next Y | 46.20% | 50D Avg Chg | -40.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -98.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -99.00% |
| Recommedations | 3.30 | Quick Ratio | 4.74 | Shares Outstanding | 58.03M | 52W Low Chg | 151.00% |
| Insider Own | 8.01% | ROA | -60.11% | Shares Float | 50.89M | Beta | 0.08 |
| Inst Own | 64.82% | ROE | - | Shares Shorted/Prior | 10.82M/14.64M | Price | 0.11 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 12,923,744 | Target Price | 20.00 |
| Oper. Margin | - | Earnings Date | Mar 27 | Volume | 31,125,310 | Change | 0.00% |
About Tricida, Inc.
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | Director Director | Nov 22 | Sell | 0.22 | 10,280,947 | 2,261,808 | 11/25/22 | |
| Alpern Robert J | Director Director | Nov 23 | Sell | 0.21 | 131,879 | 27,695 | 11/25/22 | |
| Venrock Healthcare Capital Par... | 10% Owner 10% Owner | Oct 18 | Buy | 11.17 | 351,866 | 3,930,343 | 10,202,946 | 10/20/22 |
| Venrock Healthcare Capital Par... | 10% Owner 10% Owner | Oct 13 | Buy | 11.83 | 174,966 | 2,069,848 | 9,851,080 | 10/17/22 |
| Venrock Healthcare Capital Par... | 10% Owner 10% Owner | Sep 26 | Buy | 9.29 | 587,214 | 5,455,218 | 8,881,877 | 09/28/22 |
| Venrock Healthcare Capital Par... | 10% Owner 10% Owner | Sep 02 | Buy | 11.86 | 686,712 | 8,144,404 | 8,294,663 | 09/07/22 |
| Isern Brian M. | 10% Owner 10% Owner | Aug 12 | Sell | 13.5 | 284,939 | 3,846,676 | 1,700,952 | 08/16/22 |
| Venrock Healthcare Capital Par... | 10% Owner 10% Owner | Jul 29 | Buy | 9.21 | 18,900 | 174,069 | 7,557,951 | 08/02/22 |
| Venrock Healthcare Capital Par... | 10% Owner 10% Owner | Jul 21 | Buy | 9.25 | 74,199 | 686,341 | 7,539,051 | 07/25/22 |
| Venrock Healthcare Capital Par... | 10% Owner 10% Owner | Jul 18 | Buy | 9.34 | 150,000 | 1,401,000 | 7,464,852 | 07/20/22 |
| Venrock Healthcare Capital Par... | 10% Owner 10% Owner | Jul 12 | Buy | 9.88 | 94,573 | 934,381 | 7,314,852 | 07/14/22 |
| Venrock Healthcare Capital Par... | 10% Owner 10% Owner | Jun 28 | Buy | 9.77 | 62,870 | 614,240 | 7,132,079 | 06/30/22 |
| Venrock Healthcare Capital Par... | 10% Owner 10% Owner | Jun 22 | Buy | 10.36 | 492,020 | 5,097,327 | 7,069,209 | 06/24/22 |
| Venrock Healthcare Capital Par... | 10% Owner 10% Owner | Jun 16 | Buy | 9.69 | 5,951 | 57,665 | 6,577,189 | 06/21/22 |
| Venrock Healthcare Capital Par... | 10% Owner 10% Owner | Jun 10 | Buy | 8.59 | 118,054 | 1,014,084 | 6,571,238 | 06/14/22 |
| Venrock Healthcare Capital Par... | 10% Owner 10% Owner | Jun 07 | Buy | 9.46 | 588,024 | 5,562,707 | 6,453,184 | 06/09/22 |
| Venrock Healthcare Capital Par... | 10% Owner 10% Owner | Jun 02 | Buy | 9.15 | 190,871 | 1,746,470 | 5,865,160 | 06/06/22 |
| Isern Brian M. | 10% Owner 10% Owner | Apr 26 | Sell | 11.16 | 46,099 | 514,465 | 1,794,982 | 04/28/22 |
| KLAERNER GERRIT | President and CEO President and CEO | Jan 15 | Sell | 7.3 | 16,690 | 121,837 | 507,993 | 01/15/21 |